If you are not able to view this e-mail properly, please click here to view it online
World Pharma Today Maqazine
World Pharma Today Linkedin Page World Pharma Today Facebook Page World Pharma Today Twitter Page Weekly Newsletter
Click here to subscribe to our Magazine
Top Latest Press Releases

Cryoport Launches - Cryoport. Certified. Cool

Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"), the world's leading cryogenic logistics company dedicated to the life sciences industry announced it has expanded its portfolio of cold chain logistics solutions with the launch of its 'Cryoport. Certified. Cool.' solution, which will be branded as "C3 ™"


Sangamo And Bioverativ Announce FDA Acceptance Of IND Application For ST-400

Sangamo Therapeutics, Inc. the leader in therapeutic genome editing, and Bioverativ Inc. (NASDAQ: BIVV), a global biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for hemophilia and other rare blood disorders, announced today that the U.S.


A New International Conference On The Best Of Italian Track&Trace Technologies : The Marchesini Group And Sea Vision

On October 18th, the Marchesini Group, alongside SEA Vision - the Group’s longstanding Italian partner for vision systems for pharmaceutical and OEM industries - will be at the International Conference Industry 4.0: Trends in Pharma Manufacturing...


Immatics Receives $58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies

Immatics, a leading company in the field of cancer immunotherapy, today announced the completion of its Series E financing, raising $58 million.


TrialScope Tackles Issue of “Sharing Clinical Trial Results with Patients” at CBI Conference; Presents Sponsor Survey Findings

TrialScope, the global leader in clinical trial transparency and compliance solutions, announced new findings from its sponsor survey on clinical trial results sharing practices, at CBI’s second annual Plain Language Summit in Philadelphia.


Nemera receives Drug Manufacturing Authorization for its Neuenburg plant, in Germany

Nemera received from the German Government Drug Administration (Government Presidium, Tübingen) the Pharmaceutical Drug Manufacturing Authorization according to §13 AMG (German Drug & Medicinal Product Law) at its Neuenburg manufacturing facility in Germany.


For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here


For the latest visit: www.worldpharmatoday.com

World Pharma Today